Pharmacogenetic aspects of cutaneous drug reactions
Merk, H.
Zeitschrift für Hautkrankheiten 65(3): 217-220
1990
ISSN/ISBN: 0301-0481 PMID: 2140220 Document Number: 359910
Document emailed within 1 workday
Related Documents
Kardaun, S.H. 2013: Cutaneous adverse drug reactions: clinical aspects and identification Nederlands Tijdschrift Voor Geneeskunde 157(11): A5823Souteyrand, P.; d'Incan, M.; Parent, S. 2000: Misleading or rare cutaneous drug reactions La Revue du Praticien 50(12): 1329-1333
Bonnetblanc, J.M.; Nouaille, Y. 2000: Cutaneous drug reactions: diagnosis and etiology La Revue du Praticien 50(12): 1300-1304
Herold, M.; Oltmanns, G.; Duck, H.J.; Maru, M. 1983: Severe cutaneous drug reactions: case reports Ethiopian Medical Journal 21(4): 227-232
Rademaker, M.; Oakley, A.; Duffill, M.B. 1995: Cutaneous adverse drug reactions in a hospital setting New Zealand Medical Journal 108(999): 165-166
Martins, C.R. 2006: Cutaneous drug reactions associated with newer antiretroviral agents Journal of Drugs in Dermatology: Jdd 5(10): 976-982
Khaled, A.; Kharfi, M.; Ben Hamida, M.; El Fekih, N.; El Aidli, S.; Zeglaoui, F.; Ezzine, N.; Fazaa, B.; Kamoun, M.R. 2012: Cutaneous adverse drug reactions in children. a series of 90 cases La Tunisie Medicale 90(1): 45-50
Alhenc-Gelas, Fçois.; Parmentier, L.; Bisagni, A. 2003: Pharmacogenetic and pharmacogenomic studies. Impact on drug discovery and drug development Therapie 58(3): 275-282
Kim, H.S.; Tang, M.M. 2018: Cutaneous adverse drug reactions: a four-year audit from a district hospital in Johor, Malaysia Medical Journal of Malaysia 73(6): 397-399
Krivoy, N.; Zuckerman, T.; Elkin, H.; Froymovich, L.; Rowe, J.M.; Efrati, E. 2012: Pharmacokinetic and pharmacogenetic analysis of oral busulfan in stem cell transplantation: prediction of poor drug metabolism to prevent drug toxicity Current Drug Safety 7(3): 211-217
El-Nabarawy, E.A.; Elmasry, M.F.; El Lawindi, M.I.; Tarek, Y.A. 2018: An Epidemiological and Clinical Analysis of Cutaneous Adverse Drug Reactions Seen in a Tertiary Care Outpatient Clinic in Cairo, Egypt Acta Dermatovenerologica Croatica: Adc 26(3): 233-242
Wolkenstein, P.; Charue, D.; Laurent, P.; Revuz, J.; Roujeau, J.C.; Bagot, M. 1995: Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants Archives of Dermatology 131(5): 544-551
Alván, G. 1986: Ethnic differences in reactions to drugs and xenobiotics. other protein variants with pharmacogenetic consequences: albumin and orosomucoid Progress in Clinical and Biological Research 214: 345-355
Ebbli, C.; Salomone, M.; Tagliasacchi, C.; Truffelli, L. 1982: Medico-legal aspects of drug hypersensitivity reactions Minerva Anestesiologica 48(9): 591-594
Fisher, A.A. 1987: Toxic and allergic cutaneous reactions to jellyfish with special reference to delayed reactions Cutis 40(4): 303-305
Shimoda, K. 2009: Progress on pharmacogenetic study in psychiatry and future prospects of order-made drug therapy for mental disorders Seishin Shinkeigaku Zasshi 111(12): 1546-1551
Vas, A.; Gachályi, B.; Káldor, A. 1987: Simultaneous microsomal monooxygenase enzyme system induction and inhibition, and the influence of the pharmacogenetic background: potential hazards in multi-drug therapy? International Journal of Clinical Pharmacology Therapy and Toxicology 25(7): 410
Bernstein, J.A. 1995: Nonimmunologic adverse drug reactions. how to recognize and categorize some common reactions Postgraduate Medicine 98(1): 120-122; 125-126
Thomas, K.L.H.; Ellingrod, V.L.; Bishop, J.R.; Keiser, M.J. 2010: A pilot study of the pharmacodynamic impact of SSRI drug selection and beta-1 receptor genotype (ADRB1) on cardiac vital signs in depressed patients: a novel pharmacogenetic approach Psychopharmacology Bulletin 43(1): 11-22
Mulder, W.M.; Meinardi, M.M.; Bruynzeel, D.P. 2004: Cutaneous reactions to drugs Nederlands Tijdschrift Voor Geneeskunde 148(9): 415-420